Skip to main content
Article
Changing the Trajectory of Heart Failure and Kidney Disease: A Call for Action
Clinical journal of the American Society of Nephrology : CJASN
  • Janani Rangaswami, Division of Nephrology, George Washington University School of Medicine, Washington, DC rangajanani@mfa.gwu.edu.
  • Vivek Bhalla, Division of Nephrology, Stanford University School of Medicine, Stanford, California.
  • Glenn M Chertow, Division of Nephrology, Stanford University School of Medicine, Stanford, California.
  • Robert A Harrington, Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Alexander Staruschenko, Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida.
  • Katherine Tuttle, Providence Medical Research Center, Providence Health Care, Spokane, Washington.
  • Eugene Braunwald, Thrombolysis in Myocardial Infarction Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Document Type
Journal Article
Publication Date
3-1-2022
DOI
10.2215/CJN.00470122
Keywords
  • SGLT2 inhibitors,
  • cardiorenal,
  • heart failure,
  • multidisciplinary
Department
Medicine
Citation Information
Janani Rangaswami, Vivek Bhalla, Glenn M Chertow, Robert A Harrington, et al.. "Changing the Trajectory of Heart Failure and Kidney Disease: A Call for Action" Clinical journal of the American Society of Nephrology : CJASN (2022)
Available at: http://works.bepress.com/katherine-tuttle/313/